lectin
affin
chromatographi
lac
offer
tool
aid
purif
cell
surfac
glycoconjug
suffici
quantiti
studi
address
structur
elucid
could
carri
sever
advantag
convent
biochem
method
immunoprecipit
andror
immunoaffin
chromatographi
use
purif
variou
glycoconjug
serial
lac
slac
help
establish
ident
glycoprotein
allow
purif
glycoprotein
homogen
among
mixtur
glycoprotein
also
success
resolv
microheterogen
glycoprotein
otherwis
impractic
problem
address
specif
case
alter
express
mainten
microheterogen
glycoprotein
patholog
condit
vi
vi
normal
biolog
present
applic
lac
ii
serial
fashion
iii
conjunct
techniqu
twodimension
electrophoresi
capillari
electrophoresi
mass
spectrometri
etc
diagnosi
certain
patholog
condit
possibl
use
knowledg
design
treatment
variou
diseas
discuss
q
lectin
definit
multival
protein
nonimmun
origin
bind
w
x
sugar
rather
specif
agglutin
cell
display
catalyt
activ
howw
x
ever
see
also
ref
abil
lectin
detect
subtl
variat
carbohydr
structur
found
cell
surfac
glycoprotein
glycolipid
made
w
x
paradigm
proteincarbohydr
recognit
lectin
implic
among
thing
defens
invad
organ
symbiot
associ
nitrogenfix
bacteria
root
legumin
plant
recognit
host
cell
w
x
w
x
w
x
virus
cellular
adhes
cellular
recognit
cell
growth
differenti
w
x
histochem
detect
sugar
chain
cell
surfac
stain
structur
estim
electrophoret
separ
membran
glycoconjug
also
separ
immunocyt
subset
cell
differ
differenti
stage
account
abil
specif
bind
cell
surfac
carbohydr
play
import
role
biolog
recognit
lectin
recent
past
found
extens
applic
differenti
cell
ie
blood
type
diagnosi
prognosi
cancer
elucid
architectur
dynam
cell
surfac
carbohydr
glycoconjug
purif
structur
character
reason
lectin
find
applic
across
broad
spectrum
ubiquit
distribut
natur
occur
abund
plant
especi
seed
legum
also
eas
purif
homogen
wide
repertoir
carbohydr
specif
exhibit
therefor
surpris
lectin
find
extens
applic
also
mani
aspect
biolog
medicin
cellselect
w
x
process
blood
type
analysi
oligosaccharid
isol
gate
prepar
scale
purif
glycoprotein
affin
chromatographi
cell
surfac
glycoconjug
constitut
surfac
marker
control
determin
cellligand
cellcel
interact
phenomena
cellular
signal
intercellular
signal
transduct
studi
address
molecular
mechan
process
essenti
hing
structur
elucid
membran
glycoconjug
suffici
quantiti
glycoconjug
requir
purpos
isol
convent
method
difficult
complic
w
x
occurr
microheterogen
sugar
affin
lectin
high
carbohydratespecif
antibodi
immens
practic
util
design
strategi
purif
glycoconjug
carbohydratespecif
antibodi
use
affin
ligand
unphysiolog
harsh
condit
need
employ
elut
protein
get
adsorb
onto
matrix
purif
glycoconjug
also
retent
biolog
activ
protein
purifi
circumst
guarante
lectin
contrari
immobil
employ
affin
ligand
purif
said
glycoconjug
offer
advantag
sinc
mild
condit
need
appli
elut
protein
interest
moreov
ubiquit
distribut
abund
presenc
lectin
purif
per
se
arduou
task
rais
carbohydratespecif
monoclon
antibodi
taken
togeth
fact
impli
lectin
affin
chromatographi
offer
power
tool
address
purif
membran
glycoconjug
suffici
quantiti
histor
one
problem
could
appropri
address
use
convent
mean
purif
obtain
suffici
quantiti
cell
surfac
glycoconjug
despit
central
role
play
cellular
adapt
signal
transduct
either
cours
normal
develop
patholog
situat
advent
lectin
affin
chromatographi
enabl
purif
suffici
quantiti
cell
surfac
glycoconjug
also
afford
way
fraction
resolv
mixtur
glycoprotein
exhibit
microheterogen
sugar
even
level
singl
compon
fall
beyond
scope
convent
method
principl
lectin
affin
chromatographi
similar
type
affin
chromatographi
mixtur
heterogen
glycoprotein
chromatograph
matrix
particular
lectin
immobil
glycoprotein
specif
sugar
sequenc
get
adsorb
onto
matrix
interact
immobil
lectin
glycoprotein
wash
buffer
collect
breakthrough
wash
continu
protein
come
column
use
buffer
alon
monitor
absorb
particular
wavelength
suitabl
blank
adsorb
glycoprotein
elut
column
use
sugar
complementari
structur
puriti
confirm
gel
electrophoresi
character
sugar
specif
properti
common
lectin
w
x
applic
affin
chromatographi
list
tabl
fraction
heterogen
mixtur
glycoprotein
lectin
affin
chromatographi
breakthrough
obtain
one
matriximmobil
lectin
affin
column
outlin
previou
section
rechromatograph
second
lectinaffin
column
process
repeat
differ
lectin
serial
manner
process
call
serial
lectin
affin
chromatographi
slac
addit
achiev
purif
appar
homogen
compon
mixtur
glycoprotein
slac
also
subserv
purpos
resolut
microheterogen
present
carbohydr
part
appar
homogen
glycoprotein
primarili
subject
mixtur
heterogen
glycoprotein
affin
chromatographi
matrix
particular
lectin
immobil
natur
sugar
linkag
pattern
constitu
monosaccharid
either
confirm
rule
depend
whether
glycoprotein
bind
column
come
flow
flow
chromatograph
second
lectinimmobil
affin
matrix
specif
analysi
repeat
thu
slac
one
chief
mean
structur
elucid
sugar
glycoprotein
carri
combin
exoglycosidas
digest
methyl
analysi
one
put
use
slac
complet
structur
elucid
sugar
mani
slac
studi
w
x
carri
first
report
cum
kornfeld
subsew
x
quentli
endo
et
al
glycosyl
complex
posttransl
modif
result
extens
heterogen
glycoprotein
produc
eukaryot
system
carbohydr
increas
order
mannobiosetriosepentaoseman
oligosaccharid
addit
glcnac
residu
reduc
end
trios
pentaos
enhanc
potenc
significantli
substitut
nonreduc
end
increas
potenc
margin
howev
best
mannooligosaccharid
ligand
man
glcnac
asn
bear
sever
link
mannos
residu
man
glcnac
exhibit
highest
bind
affin
w
x
lectin
known
show
specif
heavi
bchain
contain
nlink
oligosaccharid
fel
found
partial
truncat
exist
sever
isoform
glycan
heterogen
triantennari
complex
type
structur
heterogen
caus
termin
sialic
acid
fucos
residu
attach
bgalactos
residu
transferrin
haptoglobin
highresolut
twodimension
elecserum
glycoprotein
patient
show
bchain
glycoprotein
trophoresi
sodium
dodecyl
cathod
shift
decreas
mass
twodimicroheterogen
serum
liver
sulfatepolyacrylamid
gel
electrophoremension
pattern
immunodetect
precursor
patient
carbohydratedefici
si
sdspage
serum
protein
liver
cell
patient
glycoprotein
syndrom
type
cdg
show
abnorm
lowmass
precursor
absenc
precursor
normal
found
control
result
suggest
abnorm
precursor
accumul
earli
oligossaccharid
process
nascent
proteinbound
oligosaccharid
glycoprotein
precursor
undergo
alter
intracellular
transport
posttransl
process
along
normal
pathway
still
appar
function
patient
cdg
w
x
glycoform
heterogen
follicl
con
asac
chang
gonadotropin
glycoform
occur
stimul
hormon
fsh
luteinizthrough
menstrual
cycl
relat
ing
hormon
lh
normal
chang
prevail
steroid
environ
menstrual
cycl
postfollow
menopaus
oestrogen
loss
remenopaus
state
sult
acid
rel
simpl
glycoform
w
x
sugar
sequenc
branch
structur
gcclcrm
posit
ion
mode
identif
man
glcnac
man
glcnac
abund
sialic
acidrich
compon
aggreg
form
elut
mm
galactos
abund
sialic
acidpoor
compon
applic
ce
analysi
indic
monomer
compos
rel
complet
molecul
respect
glycoform
rather
aggreg
moieti
glycoprotein
may
affect
immunogen
halflif
bioactiv
w
x
stabil
potenti
therapeut
product
put
glycoprotein
among
challeng
product
character
extrem
fine
natur
w
x
sampl
microheterogen
natur
microheterogen
glycoprotein
w
x
condit
aris
due
variat
carbohydr
moieti
variat
either
due
incomplet
biosynthet
sequenc
due
postsynthet
degrad
within
cell
isol
protein
sinc
nacetylneuramin
acid
form
termin
sugar
glycoprotein
desialyl
lead
exposur
galactos
residu
strike
role
expos
galactos
residu
surviv
time
fate
glycoprotein
vivo
w
x
demonstr
ashwel
morel
moreov
rate
extent
uptak
protein
liver
parenchym
cell
determin
number
galactos
w
x
residu
expos
surfac
glycoprotein
therefor
isol
sialylglycoprotein
differ
stage
sialylationdesialyl
help
delin
quantit
uptak
basi
number
galactos
site
expos
one
pioneer
studi
address
gm
resolut
artifici
gener
demonstr
microheterogen
subsequ
amplif
bind
w
x
monoval
galactos
specif
lectin
ricin
elegantli
shown
surolia
et
al
use
simpl
techniqu
lectin
affin
chromatographi
follow
gel
filtrat
studi
microheterogen
popul
glycoprotein
fetuin
found
bind
molecul
galactosebind
lectin
ricin
proport
degre
desialyl
former
number
galactos
moieti
expos
result
monitor
differ
molecular
weight
fetuinricin
complex
form
radioiodin
ricin
nativ
fetuin
could
resolv
differ
microheterogen
group
method
could
find
applic
purif
sever
glycoprotein
homogen
also
resolut
mircoheterogen
addit
lectin
affin
chromatographi
mani
techniqu
mass
spectrometri
ionexchang
chromatographi
differ
form
capillari
electrophoresi
high
resolut
twodimension
electrophoresi
put
use
resolv
gm
techniqu
gener
use
conjunct
lectin
affin
w
x
chromatographi
list
tabl
mass
spectral
techniqu
especi
indispens
tool
detail
analysi
coval
structur
protein
w
x
particularli
refractori
standard
approach
protein
chemistri
tabl
applic
slac
pioneer
cum
kornfeld
exploit
great
degre
success
kobata
et
al
studi
alter
glycosyl
w
x
henc
diagnosi
certain
diseas
depict
clear
forego
studi
factor
respons
susten
gm
per
se
healthi
organ
alter
manifest
clinic
condit
central
import
understand
gener
also
determin
prospect
use
diagnosi
treatment
patholog
w
x
condit
although
much
made
phenomenon
earlier
gm
tabl
applic
serial
lectin
affin
chromatographi
slac
resolut
glycoprotein
microheterogen
acut
encephalomyel
subsequ
death
demyelin
diseas
surviv
anim
attribut
jhm
strain
mous
hepat
viru
neurotrop
coronaviru
known
mediat
reflect
alter
w
x
express
microheterogen
speplom
glycoprotein
glycoprotein
exhibit
diseasestatealt
charact
microheterogen
ferritin
serv
addit
tool
diagnosi
still
diseas
acut
system
w
x
inflammatori
disord
transferrin
implic
chronic
alcohol
abus
w
x
major
depress
fact
appear
desialotransferrin
detf
serum
report
biochem
marker
chronic
alcohol
alcohol
liver
diseas
pattern
variabl
transferrin
structur
pregnanc
iron
defici
anemia
women
use
oral
contracept
nonanaem
rheumatoid
arthriti
iron
defici
rheumatoid
arthriti
anemia
chronic
diseas
report
w
x
addit
applic
lectin
affin
chromatographi
supplement
convent
diagnost
tool
uncommon
one
case
point
human
chorion
gonadotropin
hcg
glycoprotein
hormon
produc
trophoblast
placenta
high
level
hcg
blood
urin
also
detect
patient
variou
trophoblast
diseas
hydatidiform
mole
choriocarcinoma
therefor
urinari
serum
hcg
measur
use
marker
diagnosi
prognosi
trophoblast
diseas
well
normal
pregnanc
mani
sensit
method
determin
level
hcg
biolog
materi
develop
none
provid
way
discrimin
hcg
normal
pregnant
women
variou
trophoblast
diseas
differenti
diagnosi
trophoblast
diseas
essenti
indispens
correct
treatment
diseas
hydatidiform
mole
consid
essenti
benign
lesion
although
rate
incid
choriocarcinoma
patient
diseas
much
higher
normal
pregnanc
hydatidiform
mole
show
appar
malign
characterist
other
invas
surround
tissu
metastasi
discrimin
typic
mole
name
invas
mole
although
prophylact
chemotherapi
effect
reduc
develop
persist
gestat
trophoblast
diseas
invas
mole
choriocarcinoma
use
chemotheraphi
time
molar
evacu
controversi
drug
toxic
thu
method
discrimin
invas
mole
hydatidiform
mole
would
w
x
use
avoid
indiscrimin
prophylact
chemotherapi
investig
structur
carbohydr
moieti
hcg
purifi
urin
patient
variou
trophoblast
diseas
reveal
although
hcg
contain
four
asparaginelink
sugar
chain
one
molecul
structur
differ
depend
diseas
accordingli
method
specif
detect
hcg
contain
neuaca
neuaca
man
group
sugar
moieti
could
use
discrimin
patient
invas
mole
choriocarcinoma
pregnant
women
patient
w
x
hydatidiform
mole
endo
et
al
found
stramonium
agglutinin
dsa
sepharos
column
fraction
oligosaccharid
three
goup
saccharid
either
man
group
group
nonsubstitut
form
bound
column
elut
buffer
contain
bnacetylglucosamin
oligom
oligosaccharid
nonsubstitut
man
group
retard
column
elut
buffer
oligosaccharid
contain
none
group
describ
group
either
sialyl
fucosyl
form
pass
column
without
interact
bind
specif
dsasepharos
column
thu
use
distinguish
malign
hcg
normal
counterpart
anoth
exampl
appli
lac
supplementari
diagnost
tool
detect
isol
human
afoetoprotein
serum
afoetoprotein
normal
produc
foetal
hepatocyt
detect
serum
week
birth
certain
liver
diseas
may
reappear
serum
first
year
life
glycoprotein
also
synthes
primari
liver
cell
carcinoma
presenc
serum
therefor
great
diagnost
signific
concentr
albumin
normal
serum
high
compar
singl
glycoprotein
specif
time
high
human
afoetoprotein
primarili
difficult
protocol
purifi
afoetoprotein
due
lesser
rel
abund
compound
similar
foetoprotein
albumin
regard
physicochem
properti
molecular
weight
isoelectr
point
electrophoret
mobil
thu
almost
insepar
wherea
immunochem
precipit
method
use
resolut
two
protein
known
effici
far
separ
concern
involv
long
tediou
process
subsequ
resolut
difficulti
pose
similar
imposs
use
convent
method
con
sepharos
affin
chromatographi
part
twostep
chemic
method
purif
human
w
x
afoetoprotein
free
albumin
report
page
success
separ
two
compon
lectinsepharos
help
distinguish
glycoprotein
minor
microheterogen
applic
medicin
list
tabl
